OUR PRICING Initial Hormone Consultation with comprehensive labs (MEN + WOMEN) Includes: comprehensive lab panel and formal consultation/evaluation/plan
A Phase 2 trial (a mid-stage human trial, typically involving a few hundred participants) published in the New England Journal of Medicine in 2023 reported an average weight loss of about 24% at 48 weeks with the highest dose
Chinas Ozempic Moment: Generics, Scale, and a Growing Weight Problem Novo Nordisks core semaglutide compound patent expired today in China on March 20, 2026 and the race that has been building behind that date is already well underway
With shortages for Wegovy and Zepbound now resolved, the FDAs notice period to large-scale compounding facilities ended in May 2025
Our formulations are designed with transparency in mind, ensuring that you know exactly what youre putting into your body
The RAAC Experience: What to Expect The process of receiving a vita glow infusion is designed to be both therapeutic and relaxing